Mankind Pharma Limited (BOM:543904)

India flag India · Delayed Price · Currency is INR
2,204.70
-3.65 (-0.17%)
At close: Dec 5, 2025
-15.11%
Market Cap 910.34B
Revenue (ttm) 135.46B
Net Income (ttm) 17.51B
Shares Out n/a
EPS (ttm) 42.63
PE Ratio 51.99
Forward PE 39.27
Dividend 1.00 (0.05%)
Ex-Dividend Date Aug 8, 2025
Volume 6,753
Average Volume 150,282
Open 2,206.05
Previous Close 2,208.35
Day's Range 2,192.00 - 2,214.15
52-Week Range 2,115.50 - 3,050.00
Beta n/a
RSI 33.20
Earnings Date Jan 23, 2026

About Mankind Pharma

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory diseases, etc. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, oral contraceptives, antacid powders, vitamin a... [Read more]

Industry Pharmaceutical Preparations
Founded 1991
Employees 26,978
Stock Exchange Bombay Stock Exchange
Ticker Symbol 543904
Full Company Profile

Financial Performance

In 2024, Mankind Pharma's revenue was 122.07 billion, an increase of 18.98% compared to the previous year's 102.60 billion. Earnings were 19.91 billion, an increase of 4.08%.

Financial Statements

News

There is no news available yet.